vs
Side-by-side financial comparison of NACCO INDUSTRIES INC (NC) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $66.8M, roughly 1.1× NACCO INDUSTRIES INC). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -5.2%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 11.9%).
NACCO Industries, Inc. is an American publicly traded holding company, headquartered in Cleveland, Ohio. Through a portfolio of mining and natural resources businesses, the company operates under three business segments: Coal Mining, North American Mining, and Minerals Management. The Coal Mining segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The North American Mining se...
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
NC vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $66.8M | $75.5M |
| Net Profit | $-3.8M | — |
| Gross Margin | 18.0% | 69.3% |
| Operating Margin | 11.3% | 22.7% |
| Net Margin | -5.8% | — |
| Revenue YoY | -5.2% | 27.7% |
| Net Profit YoY | -150.8% | — |
| EPS (diluted) | $-0.53 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $66.8M | $75.5M | ||
| Q3 25 | $76.6M | $54.5M | ||
| Q2 25 | $68.2M | $52.4M | ||
| Q1 25 | $65.6M | $46.0M | ||
| Q4 24 | $70.4M | $59.1M | ||
| Q3 24 | $61.7M | $80.5M | ||
| Q2 24 | $52.3M | $47.1M | ||
| Q1 24 | $53.3M | $43.8M |
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $13.3M | $8.8M | ||
| Q2 25 | $3.3M | $5.9M | ||
| Q1 25 | $4.9M | $3.0M | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $15.6M | $20.3M | ||
| Q2 24 | $6.0M | $-4.5M | ||
| Q1 24 | $4.6M | $-4.8M |
| Q4 25 | 18.0% | 69.3% | ||
| Q3 25 | 13.0% | 77.7% | ||
| Q2 25 | 10.0% | 76.5% | ||
| Q1 25 | 14.7% | 77.1% | ||
| Q4 24 | 12.0% | 76.4% | ||
| Q3 24 | 11.7% | 63.9% | ||
| Q2 24 | 13.4% | 77.4% | ||
| Q1 24 | 13.2% | 75.5% |
| Q4 25 | 11.3% | 22.7% | ||
| Q3 25 | 8.8% | 17.6% | ||
| Q2 25 | -0.1% | 12.7% | ||
| Q1 25 | 11.7% | 8.7% | ||
| Q4 24 | 5.5% | 22.6% | ||
| Q3 24 | 31.9% | 27.4% | ||
| Q2 24 | 14.1% | -4.6% | ||
| Q1 24 | 8.9% | -5.3% |
| Q4 25 | -5.8% | — | ||
| Q3 25 | 17.3% | 16.2% | ||
| Q2 25 | 4.8% | 11.2% | ||
| Q1 25 | 7.5% | 6.5% | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 25.4% | 25.2% | ||
| Q2 24 | 11.4% | -9.6% | ||
| Q1 24 | 8.6% | -11.0% |
| Q4 25 | $-0.53 | $0.26 | ||
| Q3 25 | $1.78 | $0.17 | ||
| Q2 25 | $0.44 | $0.12 | ||
| Q1 25 | $0.66 | $0.06 | ||
| Q4 24 | $0.99 | $0.40 | ||
| Q3 24 | $2.14 | $0.41 | ||
| Q2 24 | $0.81 | $-0.09 | ||
| Q1 24 | $0.61 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $49.7M | $97.5M |
| Total DebtLower is stronger | $100.8M | $22.7M |
| Stockholders' EquityBook value | $429.2M | $130.3M |
| Total Assets | $661.2M | $216.3M |
| Debt / EquityLower = less leverage | 0.23× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $49.7M | $97.5M | ||
| Q3 25 | $52.7M | $94.4M | ||
| Q2 25 | $49.4M | $96.0M | ||
| Q1 25 | $61.9M | $93.2M | ||
| Q4 24 | $72.8M | $101.0M | ||
| Q3 24 | $63.1M | $96.7M | ||
| Q2 24 | $62.4M | $96.8M | ||
| Q1 24 | $61.8M | $107.2M |
| Q4 25 | $100.8M | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $99.4M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | $29.0M | $90.7M | ||
| Q1 24 | $28.4M | $102.0M |
| Q4 25 | $429.2M | $130.3M | ||
| Q3 25 | $426.4M | $115.3M | ||
| Q2 25 | $413.1M | $104.7M | ||
| Q1 25 | $409.1M | $97.1M | ||
| Q4 24 | $404.9M | $92.1M | ||
| Q3 24 | $397.3M | $71.1M | ||
| Q2 24 | $384.1M | $48.5M | ||
| Q1 24 | $381.6M | $51.0M |
| Q4 25 | $661.2M | $216.3M | ||
| Q3 25 | $637.6M | $202.9M | ||
| Q2 25 | $631.3M | $194.9M | ||
| Q1 25 | $634.2M | $196.2M | ||
| Q4 24 | $631.7M | $213.3M | ||
| Q3 24 | $597.4M | $220.7M | ||
| Q2 24 | $560.1M | $205.0M | ||
| Q1 24 | $538.0M | $214.1M |
| Q4 25 | 0.23× | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 0.25× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | 0.08× | 1.87× | ||
| Q1 24 | 0.07× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.4M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.4M | $14.4M | ||
| Q3 25 | $42.3M | $9.7M | ||
| Q2 25 | $-7.8M | $14.1M | ||
| Q1 25 | $5.0M | $3.6M | ||
| Q4 24 | $25.2M | $15.6M | ||
| Q3 24 | $2.8M | $11.0M | ||
| Q2 24 | $4.1M | $1.0M | ||
| Q1 24 | $-9.8M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 3.19× | 1.10× | ||
| Q2 25 | -2.39× | 2.41× | ||
| Q1 25 | 1.03× | 1.21× | ||
| Q4 24 | 3.33× | — | ||
| Q3 24 | 0.18× | 0.54× | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | -2.14× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NC
| Transferred Over Time | $42.7M | 64% |
| Transferred At Point In Time | $24.1M | 36% |
PBYI
Segment breakdown not available.
